CASI Pharmaceuticals, Inc.
CASI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $26,642 | $18,297 | $33,464 | $43,844 |
| - Cash | $4,685 | $6,740 | $10,897 | $13,468 |
| + Debt | $18,855 | $18,734 | $18,492 | $22,141 |
| Enterprise Value | $40,812 | $30,291 | $41,059 | $52,517 |
| Revenue | $3,075 | $4,175 | $6,240 | $13,356 |
| % Growth | -26.3% | -33.1% | -53.3% | – |
| Gross Profit | $706 | $2,058 | $3,619 | $3,228 |
| % Margin | 23% | 49.3% | 58% | 24.2% |
| EBITDA | -$10,105 | -$10,957 | -$10,553 | -$9,757 |
| % Margin | -328.6% | -262.4% | -169.1% | -73.1% |
| Net Income | -$10,883 | -$13,375 | -$10,750 | -$14,370 |
| % Margin | -353.9% | -320.4% | -172.3% | -107.6% |
| EPS Diluted | -0.68 | -0.86 | -0.69 | -0.93 |
| % Growth | 20.9% | -24.6% | 25.8% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |